VVOS
Vivos Therapeutics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$10.89M
P/E Ratio
—
EPS
$-2.07
Beta
6.90
52W High
$7.95
52W Low
$0.76
50-Day MA
$1.23
200-Day MA
$2.57
Dividend Yield
—
Profit Margin
-121.40%
Forward P/E
—
PEG Ratio
—
About Vivos Therapeutics Inc
Vivos Therapeutics, Inc., a medical technology company, is dedicated to developing and commercializing treatment alternatives for patients with sleep-disordered breathing, such as mild to moderate obstructive sleep apnea (OSA). The company is headquartered in Highlands Ranch, Colorado.
Fundamentals
| Revenue (TTM) | $17.44M |
| Gross Profit (TTM) | $10.54M |
| EBITDA | $-18.59M |
| Operating Margin | -166.90% |
| Return on Equity | -663.00% |
| Return on Assets | -61.50% |
| Revenue/Share (TTM) | $1.70 |
| Book Value | $0.31 |
| Price-to-Book | 6.86 |
| Price-to-Sales (TTM) | 0.63 |
| EV/Revenue | 1.282 |
| EV/EBITDA | -0.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 3.40% |
| Shares Outstanding | $13.61M |
| Float | $12.75M |
| % Insiders | 26.47% |
| % Institutions | 8.13% |
Historical Volatility
HV 10-Day
100.54%
HV 20-Day
140.21%
HV 30-Day
124.70%
HV 60-Day
97.47%
HV Rank
95.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($2.42 target)
2
Buy1
HoldData last updated: 5/1/2026